Clinical trial on prevention as well as reduction of chemotherapy-induced neuropathy with acupuncture treatment on the breast cancer patients

Chemotherapy - Induced Peripheral Neuropathy

计划入组 22 人 · 首次发布于 2021 年 11 月 30 日

Chemotherapy Induced Peripheral Neuropathy (CIPN)

计划入组 44 人 · 首次发布于 2017 年 9 月 6 日

peripherally-restricted NLRP3 inhibitor (peripheral neuropathy)

Peripherally-restricted allosteric SARM1 inhibitor (peripheral neuropathy)

AAV based SARM1 gene therapy (peripheral neuropathy/neurological disorders)

Bard Peripheral Vascular, Inc.

United States

HARVEST TRAVEL & LEISURE INCOME ETF UNIT CL A

United States

NeuroBo Pharmaceuticals

United States

Phase III Trial Tests Yoga as Non-Pharmacological Treatment for Chemotherapy-Induced Peripheral Neuropathy

Asahi Kasei Pharma Initiates Phase III Trial of ART-123 for Chemotherapy-Induced Peripheral Neuropathy Prevention

Psilocybin prevents chemotherapy-induced peripheral neuropathy in preclinical models, paving the way for a Phase 2 trial